Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 65936
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
65936
Date of registration
18.09.2017
Company name
Novartis Pharma Schweiz AG
Revision date
Valid until
17.09.2022
Indication
Date of market entry
Index Therapeuticus (BSV)
Revocation Date
Index Therapeuticus (Swissmedic)
06.99.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Revolade 25mg
Pulver zur Herstellung einer oralen Suspension
Soluble Powder (Eltrombopagum 25 mg)
B02BX05
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
